The DOI matches its Crossref record; 53 of the 54 references it cites were found in a registry or an index.
Membrane-destabilizing ionizable phospholipids for organ-selective mRNA delivery and CRISPR–Cas gene editing
Open accessAbstract
Endosomal escape remains a fundamental barrier hindering the advancement of nucleic acid therapeutics. Taking inspiration from natural phospholipids that comprise biological membranes, we report the combinatorial synthesis of multi-tailed ionizable phospholipids (iPhos) capable of delivering messenger RNA or mRNA/single-guide RNA for gene editing in vivo. Optimized iPhos lipids are composed of one pH-switchable zwitterion and three hydrophobic tails, which adopt a cone shape in endosomal acidic environments to facilitate membrane hexagonal transformation and subsequent cargo release from endosomes. Structure-activity relationships reveal that iPhos chemical structure can control in vivo efficacy and organ selectivity. iPhos lipids synergistically function with various helper lipids to formulate multi-component lipid nanoparticles (called iPLNPs) for selective organ targeting. Zwitterionic, ionizable cationic and permanently cationic helper lipids enable tissue-selective mRNA delivery and CRISPR-Cas9 gene editing in spleen, liver and lungs (respectively) following intravenous administration. This rational design of functional phospholipids demonstrates substantial value for gene editing research and therapeutic applications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Organ selectivity can also be achieved by adjusting the proportions of lipid components, for example, to design spleen-targeted mRNA vaccines26,27 or lung-targeted genome editing delivery systems114,134.”
From Lipid nanoparticles for mRNA delivery (2021) · cites this paper as [114]
In the citing paper
“Moreover, the delivery efficacy of mRNA could be improved, for example, by rational design of lipids through modulation of head groups and hydrophobic tails to increase cellular uptake and endosomal escape of lipid nanoparticle–mRNA formulations64,66,76–78,88,97,100,114,140,141.”
From Lipid nanoparticles for mRNA delivery (2021) · cites this paper as [114]
In the citing paper
“For example, alteration of the alkyl length of a lipid results in selective accumulation of lipid nanoparticle–mRNA formulations in the liver or spleen114.”
From Lipid nanoparticles for mRNA delivery (2021) · cites this paper as [114]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
Membrane lipids: where they are and how they behave
van Meer, G., Voelker, D. R., & Feigenson, G. W. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2330 · Cited by 7,157
Cheng, Q., Wei, T., Farbiak, L., Johnson, L. T., Dilliard, S. A., & Siegwart, D. J. (2020) · Nature Nanotechnology · doi:10.1038/s41565-020-0669-6 · Cited by 2,383
Self-citationRational design of cationic lipids for siRNA delivery
Semple, S. C., Akinc, A., Chen, J., Sandhu, A. P., Mui, B. L., Cho, C. K., Sah, D. W. Y., Stebbing, D., Crosley, E. J., Yaworski, E., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1602 · Cited by 1,822
Delivery materials for siRNA therapeutics
Kanasty, R., Dorkin, J. R., Vegas, A., & Anderson, D. (2013) · Nature Materials · doi:10.1038/nmat3765 · Cited by 1,800
Gilleron, J., Querbes, W., Zeigerer, A., Borodovsky, A., Marsico, G., Schubert, U., Manygoats, K., Seifert, S., Andree, C., Stöter, M., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2612 · Cited by 1,681
The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs
Akinc, A., Maier, M. A., Manoharan, M., Fitzgerald, K., Jayaraman, M., Barros, S., Ansell, S., Du, X., Hope, M. J., Madden, T. D., et al. (2019) · Nature Nanotechnology · doi:10.1038/s41565-019-0591-y · Cited by 1,636
Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo
Jayaraman, M., Ansell, S. M., Mui, B. L., Tam, Y. K., Chen, J., Du, X., Butler, D., Eltepu, L., Matsuda, S., Narayanannair, J. K., et al. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201203263 · Cited by 1,267
Cited by
Sorted by citations
Items 401–500 of 652
Liu, M., Xu, L., Jiang, J., Dong, H., Zhu, P., Cao, L., Chen, J., & Zhang, X. (2023) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10558 · Cited by 9
Iron‐Confined CRISPR/Cas9‐Ribonucleoprotein Delivery System for Redox‐Responsive Gene Editing
Qiu, L., Sun, M., Chen, L., Jiang, J., Fu, Z., Wang, Y., Bi, Y., Guo, Q., Bai, H., Chen, S., et al. (2024) · Small · doi:10.1002/smll.202309431 · Cited by 10
Fan, J., Qi, W. D., Yuan, P., Xiao, B., Yao, S., Xu, H., Liu, J., Li, R., Shen, Y., Slater, N. K. H., et al. (2025) · Chem & Bio Engineering · doi:10.1021/cbe.5c00031 · Cited by 10
Tan, R., Huang, G., Wei, C., He, Z., Zhao, T., Shi, Y., Liu, Z., & Chen, Y. (2024) · Journal of Polymer Science · doi:10.1002/pol.20240154 · Cited by 9
Liu, Y., Zhang, R., Qiu, N., Wang, S., Chen, J., Xu, X., Xiang, J., & Shen, Y. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202417101 · Cited by 9
Yang, N., Sun, Q., Wang, Y., Mei, D., Wang, X., Zhang, J., Liu, D., Huo, R., Tian, Y., Su, Y. R., et al. (2024) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2024.101011 · Cited by 9
“Consequently, it induces a pronounced tendency for membrane phase transition and subsequent RNA release from endosomes, improving RNA cytosolic delivery of LNPs [ 16 ,17 ].”
Khalifeh, M., Egberink, R. O., Roverts, R., & Brock, R. E. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.125109 · Cited by 9
Molecular Imaging for Biomimetic Nanomedicine in Cancer Therapy: Current Insights and Challenges
Hu, W., Li, M., Yuan, F., Wang, X., Yang, S., Gao, Y., Jiang, D., & Lan, X. (2025) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c19720 · Cited by 9
Guo, H., Hong, J., Zhu, Y., Gui, H., Liu, H., Ren, R., Li, Y., Shan, S., Guan, Z., Liu, M., et al. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.113624 · Cited by 9
Native Top–Down Analysis of Membrane Protein Complexes Directly From In Vitro and Native Membranes
Jung, W., Panda, A., Lee, J., Ghosh, S., Shaw, J., & Gupta, K. (2025) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2025.100993 · Cited by 11
“Our inspiration came from the fi eld of lipid vesicle – based drug delivery, where protonatable lipids are embedded in the membrane to destabilize it from within through selective protonation at the acidic endolysosomal systems (71).”
Developing Biomaterial‐Based mRNA Delivery System for Lung Disease Treatment
Gu, Q., Xue, H., Liu, Z., Rao, J., Zeng, L., Zhang, C., Lei, L., & Shi, L. (2025) · Advanced Science · doi:10.1002/advs.202505413 · Cited by 11
Zhao, H., Gao, Y., Qi, Y., An, Z., Li, M., Chen, J., Ma, S., Song, W., & Chen, X. (2025) · ACS Nano · doi:10.1021/acsnano.5c12386 · Cited by 10
Microrobots for pulmonary drug delivery
Li, Z., Luan, H., Fang, Z., Ding, S., Kobrin, R., Fang, R. H., Zhang, L., & Wang, J. (2026) · Nature Reviews Bioengineering · doi:10.1038/s44222-025-00381-8 · Cited by 14
Chen, S., Le, Z., Gu, J., Liu, L., Liu, Z., & Chen, Y. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c02198 · Cited by 9
Delivery of nucleic acid drugs for tumor therapy: Opportunities and challenges
Sun, D., Tan, W., Zhao, J., Tian, Y., Li, S., Zhang, Z., Dong, X., Liu, X., Liu, N., Jiao, P., et al. (2024) · Fundamental Research · doi:10.1016/j.fmre.2023.11.020 · Cited by 10
“It is believed that the negatively charged phosphate group promotes membrane fusion and induces endosomal escape, allowing formulation 9A1P9 to preferentially deliver targeted nucleic acids to the liver and lungs [91] .”
pH-Triggered Assembly of Endomembrane Multicompartments in Synthetic Cells
Lussier, F., Schröter, M., Diercks, N. J., Jahnke, K., Weber, C., Frey, C., Platzman, I., & Spatz, J. P. (2021) · ACS Synthetic Biology · doi:10.1021/acssynbio.1c00472 · Cited by 11
Dong, X., Pan, P., Zhang, Q., Ye, J., Bao, P., Zeng, X., & Zhang, X. (2022) · Nano Today · doi:10.1016/j.nantod.2022.101555 · Cited by 9
Zheng, Q., Wang, W., Zhou, Y., Mo, J., Chang, X., Zha, Z., & Zha, L. (2023) · Biomaterials Science · doi:10.1039/d3bm00788j · Cited by 10
Poly(ethylene glycol) Cross-Linked Antibody Nanoparticles for Tunable Biointeractions
Hu, Y., Cortez‐Jugo, C., Ju, Y., Zheng, T., Zhou, J., Lin, Z., Rose, R. D., Hagemeyer, C. E., Alt, K., & Caruso, F. (2023) · Chemistry of Materials · doi:10.1021/acs.chemmater.3c00323 · Cited by 9
Cao, X., Su, L., & Chen, H. (2024) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2024.114296 · Cited by 8
Chen, C., Zhang, Y., Cao, Z., Li, D., Zhu, Y., Jing, H., Li, Y., Li, F., Xu, C., Yang, X., et al. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202406101 · Cited by 8
Gao, W., Bai, Y., Yang, Y., Jia, L., Mi, Y., Cui, W., Liu, D., Shakoor, A., Zhao, L., Li, J., et al. (2024) · Applied Physics Reviews · doi:10.1063/5.0211141 · Cited by 8
Paranthaman, S., Uthaiah, C. A., Md, S., & Alkreathy, H. M. (2025) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2025.103497 · Cited by 8
Unlocking the full therapeutic potential of lipid nanoparticles through extrahepatic delivery
Truong, H. Q., & Meng, F. (2025) · Nano Research · doi:10.26599/nr.2025.94907422 · Cited by 9
Tailoring Alkyl Side Chains of Ionizable Amino-Polyesters for Enhanced In Vivo mRNA Delivery
Espinar, A. L., Mulder, L. M., Elkhashab, M., Khan, Z., Czarnocki‐Cieciura, M., Aburto, M. R., Vučen, S. R., & Kowalski, P. S. (2025) · ACS Applied Bio Materials · doi:10.1021/acsabm.5c00116 · Cited by 8
Cost-effective yet high-performance ionizable lipids for mRNA-lipid nanoparticle vaccines
Gao, Z., Yang, H., He, Z., Zhou, Y., Ge, X., Liu, H., Yan, Z., Wang, H., Wei, L., Qiao, D., et al. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123421 · Cited by 9
CRISPR/Cas bioimaging: From whole body biodistribution to single-cell dynamics
Kolesova, E. P., Pulone, S., Kostyushev, D. S., & Tasciotti, E. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115619 · Cited by 9
Lipid Nanoparticle Development for A Fluvid mRNA Vaccine Targeting Seasonal Influenza and SARS-CoV-2
Felgner, J. H., Hernandez‐Davies, J. E., Strahsburger, E., Silzel, E. K., Nakajima, R., Jain, A., Laster, J., Chiang, J.-L., Tsai, Y.-L., Felgner, P. L., et al. (2025) · npj Vaccines · doi:10.1038/s41541-025-01153-6 · Cited by 10
“Other synthetic helper lipids have also been identi fi ed to enhance vesicle fusion or improve endosomal escape 37,38 , or to help target speci fi c organs such as lungs or spleens 39,40 .”
ApoE2-DARPin fusion proteins enable selective RNA transfer to CD8 T cells by lipid nanoparticles
Theuerkauf, S. A., Zinser, L. J., Sheth, N., Adabi, E., Knapp, L. R., Gorol, J. M., Hein, S., Chroni, A., Thalheimer, F. B., & Buchholz, C. J. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114377 · Cited by 9
Transporting via Neutrophil as a Key Mechanism for Nanoparticle Redistribution to Tumor and Spleen
Wang, S., Mei, P., Huang, J., Zhao, X., Zhang, Y., Guo, X., Zhou, H., Zhu, Y., Liu, X., Jin, Z., et al. (2025) · ACS Nano · doi:10.1021/acsnano.5c14907 · Cited by 8
A material toolbox for engineering targeted lipid nanoparticles for RNA therapies
Yoo, S., Ang, M. J. Y., Murray, A. M., & Mitchell, M. J. (2026) · Materials Today · doi:10.1016/j.mattod.2025.12.034 · Cited by 9
Tian, Z., Wang, X., Chatterjee, S., Miller, W., Guerrero, E. D., Sung, Y., Benitez, A. P., Dilliard, S. A., Bian, X., Vaidya, A., et al. (2026) · Nature Biomedical Engineering · doi:10.1038/s41551-026-01615-9 · Cited by 10
Self-citationGong, F., Xu, Y., Chen, J., Zhang, S., Dong, S., Healy, L., Seto, B. Y., Zhou, M., Lu, R. X. Z., Li, G., et al. (2026) · Nature Materials · doi:10.1038/s41563-026-02555-0 · Cited by 8
Wu, J., Chen, G., Fan, C., Shen, F., Yang, Y., Pang, W., Zhao, Z., Guan, H., Wu, H., Lu, Y., et al. (2023) · Advanced Functional Materials · doi:10.1002/adfm.202306010 · Cited by 8
Responsive Zwitterionic Materials for Enhanced Drug Delivery
Zheng, K., Ouyang, X., Hong, X., & Peng, S. (2025) · Langmuir · doi:10.1021/acs.langmuir.4c04809 · Cited by 8
Leav, B. A., Straus, W. L., White, P., Leav, A., Gaines, T., Maggiacomo, G., Kim, D., Smith, E. R., Gurwith, M., & Chen, R. T. (2022) · Vaccine · doi:10.1016/j.vaccine.2022.06.005 · Cited by 9
“The effective delivery of mRNAbased vaccines and therapies is enabled by the use of lipid nanoparticles (LNPs), which protect nucleic acid degradation by exo- and endonucleases [11,12] and facilitate cellular uptake and expression [13,14,78], Used in both the Pfizer/BioNTech and Moderna COVID-19 mRNA vaccines, this de…”
Chen, S. P., Wang, S., Liao, S., & Blakney, A. K. (2024) · ACS Bio & Med Chem Au · doi:10.1021/acsbiomedchemau.4c00085 · Cited by 7
Research Progress of Phospholipid Vesicles in Biological Field
Zhang, N., Song, J., & Han, Y. (2024) · Biomolecules · doi:10.3390/biom14121628 · Cited by 7
Xu, H., Fan, J., Liu, J., Qi, W. D., Li, R., Yuan, P., Xiao, B., Piao, Y., Sun, W., Xiang, J., et al. (2025) · Chinese Chemical Letters · doi:10.1016/j.cclet.2025.110833 · Cited by 7
Zinc‐Coordinated Lipids: Facilitators for Enhanced mRNA Delivery Efficacy
Zhang, Y., Su, K., Shi, L., Wu, S., Yan, X., Zhang, Y., Wang, Z., Wang, W., Xu, T., & Liu, S. (2025) · Angewandte Chemie International Edition · doi:10.1002/anie.202515406 · Cited by 8
Self-citationKaboudin, B., Aoyama, H., Sugiyama, A., Endo‐Takahashi, Y., & Negishi, Y. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c05685 · Cited by 7
Wang, N., & Wang, T. (2024) · Biotechnology Journal · doi:10.1002/biot.202300658 · Cited by 11
“[94,95] For instance, helper lipids may influence target organ specificity according to previous reports that cationic lipids lead the liver targeted LNPs to the lungs, whereas anionic lipids make them target the spleen.”
BackgroundConstruction of Degradable and Amphiphilic Triblock Polymer Carriers for Effective Delivery of siRNA
Yan, Y., Zhu, F., Su, H., Liu, X., Ren, Q., Huang, F., Ye, W., Zhao, M., Zhao, Y., Zhao, J., et al. (2022) · Macromolecular Bioscience · doi:10.1002/mabi.202200232 · Cited by 7
Zhang, Y., Yang, J., Liu, P., Zhang, R., Li, J.-D., Bi, Y., & Li, Y. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106509 · Cited by 7
Clinical gene therapy development for the central nervous system: Candidates and challenges for AAVs
Leong, T. W., Pal, A., Cai, Q., Gao, Z., Li, X., Bleris, L. G., Hayenga, H. N., & Qin, Z. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.04.009 · Cited by 7
Kimura, S., & Harashima, H. (2024) · BioDrugs · doi:10.1007/s40259-024-00647-4 · Cited by 8
“A library of derivatives of phospholipids, as well as ioniz-able lipids, was recently created and its use was reported to improve mRNA delivery [30, 103].”
Cationic lipid nanoparticles for nucleic acid delivery: microfluidics versus thin film hydration
Park, H., Lee, J., Kang, J.-W., Min, J.-Y., Lee, J., Hong, J., & Shim, G. (2025) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-025-00737-7 · Cited by 7
“DPhPE, a cone-shaped neutral lipid, facilitates membrane phase transformation and plays a pivotal role in endosomal escape (Tomita et al. 2013; Liu et al. 2021 ; Kim et al. 2021a).”
Wu, M., Li, J., Xu, Y., Lv, S., Wang, G., Huang, Y., Tao, Y., Ju, C., & Zhang, C. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.113779 · Cited by 6
Dendrimers Improve Apolipoprotein Nanoparticle mRNA Delivery to Immune Cells
Trines, M. M., Hoorn, D., Hofstraat, S. R. J., Zwolsman, R. C., Anbergen, T., Versteeg, I., van Elsas, Y., Deckers, J., Hendrikx, M., Kleuskens, T., et al. (2025) · Advanced Materials · doi:10.1002/adma.202504830 · Cited by 8
Engineering Delivery Technologies for Optimizing mRNA Vaccines
Gu, T., Yan, X., & Liu, S. (2025) · ACS Nano Medicine · doi:10.1021/acsnanomed.5c00032 · Cited by 7
Self-citationYu, C., Hu, Z., Hu, G., Jia, Q., Xiao, Y., Ahmad, H., Zhang, D., Liu, Z., Iqbal, M. S., Zeng, W., et al. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123770 · Cited by 7
Xiao, X., Gao, Y., Li, A., Jia, Y., Li, J., Zhang, M., Ji, R., Shen, M., Pich, A., & Shi, X. (2025) · Bioactive Materials · doi:10.1016/j.bioactmat.2025.10.008 · Cited by 6
“For example, lipid nanoparticles (LNPs) have been widely adopted in pre-clinical or clinical mRNA vaccine formulations to prevent mRNA degradation and to promote its intracellular delivery and endo/lysosomal escape [11,12].”
Aromatic Ionizable Lipids Enhance mRNA Delivery via Coordinating Multiple Mechanisms
Lin, L., Zhang, X., Yan, X., Shi, L., Su, K., He, S., Yu, M., Fu, X., Sheng, X., Kong, N., et al. (2026) · Journal of the American Chemical Society · doi:10.1021/jacs.5c16971 · Cited by 6
Self-citationSynthesis and Properties of Fluoroether Phosphocholine
Liao, C., Guo, S., Huang, M., Guo, Y., Chen, Q., Liu, C., & Zhang, Y. (2024) · 化学学报 · doi:10.6023/a23090430 · Cited by 6
Pawar, S., Pingale, P., Garkal, A., Osmani, R. A. M., Gajbhiye, K. R., Kulkarni, M., Pardeshi, K., Mehta, T. A., & Rajput, A. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.131139 · Cited by 6
RNA-lipid nanoparticle therapeutics for women’s health
Nomani, A., Saraswat, A. L., Zhang, Y., Parenky, A. C., Kuo, C.-T. J., Brown, H., Hartford, S. A., Rayaprolu, B. M., Bhalla, A. S. B., & Shameem, M. (2025) · Frontiers in Nanotechnology · doi:10.3389/fnano.2025.1475969 · Cited by 7
Nuclear‐Targeted Material Enabled Intranuclear MicroRNA Imaging for Tracking Gene Editing Process
Wu, J., Meng, M., Guo, Z., Hao, K., Liang, Y., Meng, H., Fang, G., Shi, Z., Guo, X., Li, H., et al. (2025) · Angewandte Chemie International Edition · doi:10.1002/anie.202500052 · Cited by 6
Baek, S., Jang, J., Jung, H. J., Lee, H., & Choe, Y. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03823-9 · Cited by 7
“Zwitterionic detergents efficiently dissolve membrane lipids because of their higher critical micelle concentration (CMC) [36, 37], resulting in improved non-degradative epitope recovery and membrane solubilization in thick tissues.”
Non‐Viral RNA Delivery During Pregnancy: Opportunities and Challenges
Chaudhary, N., Newby, A. N., & Whitehead, K. A. (2023) · Small · doi:10.1002/smll.202306134 · Cited by 6
Nonviral vector system for cancer immunogene therapy
Nie, W., Chen, J., Wang, B., & Gao, X. (2022) · MedComm – Biomaterials and Applications · doi:10.1002/mba2.10 · Cited by 6
The Application of Nanotechnological Therapeutic Platforms against Gynecological Cancers
Keyvani, V., Mollazadeh, S., Riahi, E., Mahmoudian, R. A., Tabari, M., Lagzian, E., Ghorbani, E., Akbarzade, H., Gholami, A.-S., Gataa, I. S., et al. (2024) · Current Pharmaceutical Design · doi:10.2174/0113816128291955240306112558 · Cited by 5
Matayoshi, K., Takahashi, S., Ryu, S., Koide, H., Yonezawa, S., Ozaki, N., Kurata, M., & Asai, T. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.125485 · Cited by 5
Lipid nanoparticle mediated mRNA delivery in cancer immunotherapy
Asthana, G. S., Bhattacharjee, S., Kumar, J., Sayyed, S., Jindal, A., Kumar, P., Chinchane, A., Bhattacharyya, A., Jaiswal, R., Kulkarni, S., et al. (2025) · Advances in immunology · doi:10.1016/bs.ai.2025.02.001 · Cited by 5
Zang, S.-S., Zhang, R., Zhang, J.-R., Zhang, X., & Li, J. (2025) · Human Gene Therapy · doi:10.1089/hum.2024.262 · Cited by 6
Emerging lipid nanoparticle systems capable of efficient intramuscular RNA delivery
Raza, A., Zhang, R., Lu, R., Wen, J., & Wu, W. (2025) · Nanomedicine · doi:10.1080/17435889.2025.2555507 · Cited by 7
Lipid nanoparticle-assisted mRNA therapy for cancer treatment
Kim, H.-J., Le, N. D., Oh, H.-J., Kim, B., Yoo, E., Kim, J., & Yim, H. (2025) · Applied Physics Reviews · doi:10.1063/5.0247029 · Cited by 5
Optimizing the targeting of lipid nanoparticles for gene therapy
Yue, L., Gao, X., Qi, W., Zhang, L., & Wang, Y. (2025) · Nanoscale Horizons · doi:10.1039/d5nh00351b · Cited by 6
mRNA vaccines for porcine reproductive and respiratory syndrome: A new paradigm in swine health
Khan, M., Taira, O., Shi, X., Wang, H., & Cai, X. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.152950 · Cited by 5
mRNA technology for the prevention and treatment of HIV-1 infection
Chuang, L. I. U., Yaremenko, A. V., Li, X., You, X., Zhu, X., Liu, N., Chen, W., Kong, N., Xie, T., Gaiha, G. D., et al. (2026) · Nature Reviews Bioengineering · doi:10.1038/s44222-025-00387-2 · Cited by 6
“Multiple clinical trials are now evaluating LNP-based HIV-1 mRNA vaccines (for example, IAVI G002, NCT05001373, IAVI G003, NCT05414786 and NCT05217641) 13,95,132 .”
Han, M., Xu, H., Yuan, J., Li, W., Zhang, H., Fang, H., Kuang, Z., Yu, Y., Wang, D., Zhao, Z., et al. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.01.017 · Cited by 5
Nano-Enabled CRISPR-Cas Gene Editing for Cancer Therapeutics
Luo, L., Sun, P., Zhang, T., Zhou, Z., Zhang, T., & Hao, Z. (2026) · Journal of Nanotheranostics · doi:10.3390/jnt7010006 · Cited by 5
“This process induces a structural transition from lamellar to hexagonal endosomal membranes, ultimately facilitating endosomal escape through mechanisms of membrane fusion and destabilization [57].”
Direct cytosolic delivery of DNA by creating fast closable holes in the cell membrane
Wang, H., You, W., Gao, F., Zhang, L., Shen, A., Wang, F., Chen, G., Nie, X., Xia, L., Huang, W., et al. (2022) · Chemical Engineering Journal · doi:10.1016/j.cej.2022.140962 · Cited by 5
He, Z., Le, Z., Shi, Y., Liu, L., Liu, Z., & Chen, Y. (2023) · Angewandte Chemie · doi:10.1002/ange.202310401 · Cited by 5
Sen, O., Sarkar, P., Das, S., Giri, N. K., Sarkar, S., Jana, S., Nandi, G., & Manna, S. (2024) · ChemistrySelect · doi:10.1002/slct.202403174 · Cited by 5
Optimizing Nucleic Acid Delivery Systems through Barcode Technology
Park, S., Kim, M., & Lee, J. W. (2024) · ACS Synthetic Biology · doi:10.1021/acssynbio.3c00602 · Cited by 6
Zhang, F., Burghardt, T., Höhn, M., & Wagner, E. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16060779 · Cited by 5
Polysorbate 80-containing ionizable lipid nanoparticles for mRNA delivery
Tang, X., Ding, S., Yang, S., Cheng, Y., Liu, H., Chen, K., & Han, X. (2024) · Biomaterials Science · doi:10.1039/d4bm00523f · Cited by 5
Enhanced mRNA delivery via incorporating hydrophobic amines into lipid nanoparticles
Wang, L., Li, Y., Jiang, P., Bai, H., Wu, C., Shuai, Q., & Yan, Y. (2025) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2025.114528 · Cited by 5
Song, S., Ma, X., Li, X., Xu, B., Li, W., Deng, R., Ye, J., Liu, Z., Yu, H., Xu, L., et al. (2025) · Nano Today · doi:10.1016/j.nantod.2025.102755 · Cited by 6
Nanoscale delivery of phytochemicals targeting CRISPR/Cas9 for cancer therapy
Hussain, Y., Khan, H. Z., Ahmad, I. I., Efferth, T., & Alam, W. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153830 · Cited by 5
In vivo assessment of triazine lipid nanoparticles as transfection agents for plasmid DNA
Nardo, D., Pitts, M. G., Kaur, R., & Venditto, V. J. (2022) · Biomaterials Science · doi:10.1039/d2bm01289h · Cited by 5
The RNA delivery dilemma—lipid versus polymer nanoparticle platforms
Martins, C., Mitchell, M. J., Peer, D., Perrie, Y., Siegwart, D. J., Alonso, M. J., & Aparicio-Blanco, J. (2026) · Drug Delivery and Translational Research · doi:10.1007/s13346-026-02044-6 · Cited by 12
“In the lipid field, the development of Selective Organ Targeting (SORT) RNA LNPs has been particularly impactful [58, 59, 111–122].”
Self-citationLi, J., & Foged, C. (2024) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2024.2409142 · Cited by 5
“Inspired by the successful optimization of cationic lipids, a library of multifunctional ionizable phospholipids (iPhos) was designed, featured with one zwitterionic headgroup combined with multiple tails to facilitate membrane phase transformation and pH-triggered membrane breakdown [84].”
Ma, J., Ding, D., Xu, R. D., Ma, S., Zhong, Y., Liu, W., Gao, L., & Chen, W. (2025) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.70037 · Cited by 4
A machine learning benchmarking framework for lipid nanoparticle transfection efficiency prediction
Mehradfar, A., Sepehri, M. S., Hernández-Lobato, J. M., Kwon, G. S., Soltanolkotabi, M., Avestimehr, S., & Rasoulianboroujeni, M. (2026) · Communications AI & Computing · doi:10.1038/s44488-026-00007-x · Cited by 9
“The precise structure–function relationships governing ionizable lipid performance remain poorly understood, necessitating the empirical screening of large lipid libraries to identify high-performing candidates [14, 15, 16, 17, 18].”
Hydrogen Bond-Assisted Two-Component Lipid Nanoparticles for Spleen-Specific mRNA Delivery
Wang, Q., Lin, Y., Luo, Z., Xiao, J., Xu, K., Yu, X., Meng, Y., Li, M., Ren, H., Liu, F., et al. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.5c14194 · Cited by 4
Self-citationPatel, J., Azhar, M., Smith, R. H., Larochelle, A., Swenson, R. E., & Vasalatiy, O. V. (2026) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.5c00608 · Cited by 4
Accelerate the Highly Efficient Development of mRNA Vaccines Through Advanced Computational Methods
Gu, R., Si, D., Lei, D., Xie, X., Li, Y., & Wen, H. (2026) · MedComm · doi:10.1002/mco2.70612 · Cited by 6
“Liu et al. developed hundreds of ionizable phospholipids termed iPhos to overcome the limitations of traditional phospholipids, such as structural inflexibility and hard-to-access reactions [ 175 ].”
Crosslinking of lipid nanoparticles enhances the delivery efficiency and efficacy of mRNA vaccines
Liu, X., Zhu, Y., Wei, C. Y., Lin, J., Yu, D., Kong, J., Shao, F., Ma, J., Xu, T., Lu, X., et al. (2026) · Nature Chemical Engineering · doi:10.1038/s44286-026-00356-5 · Cited by 4
Rational Design of Spherical Nucleic Acids: Expanding Horizons for Precision Nucleic Acid Therapy
Li, Y., Liu, S., Yang, J., Guo, S., Ao, Y., Cao, X., Qian, W., Ruan, S., Huang, Y., Weng, Y., et al. (2026) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5c25947 · Cited by 5
Self-citationRational design of lipid-based nanoparticles for targeted anticancer therapies
Arenas-Moreira, M., Ocaña, A., Alonso‐Moreno, C., & Bravo, I. (2026) · Drug Delivery and Translational Research · doi:10.1007/s13346-026-02110-z · Cited by 4
“The obligatory strategy relies on formulating LNPs with ionizable lipids to actively facilitate endosomal escape, alongside stealth coatings to prevent nuclease degradation [9, 59, 87, 88].”
Li, X., Wu, B., Lu, X., Yang, J., Zhu, Y., Yamagata, H. M., Tong, E. C., Mitchell, M. J., & Han, X. (2026) · ACS Nano Medicine · doi:10.1021/acsnanomed.6c00043 · Cited by 4
Advances in RNA delivery to extrahepatic tissues and cells
Li, Z., Guo, S., & Huang, Y. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.115170 · Cited by 4
Synthesis of novel cholesterol-based ionizable lipids for mRNA delivery
Qian, R., Ullah, A., Cui, J., Cai, X., Cao, J., Wu, L. H., & Shen, S. (2024) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2024.113980 · Cited by 4
Seshire, A., Duan, Y., & Lang, K. (2024) · Handbook of experimental pharmacology · doi:10.1007/164_2024_723 · Cited by 4
Zhou, P., Wang, M., He, T., Cai, Y., Zhang, Y., Wang, G., Sun, F., Song, G., & Li, W. (2025) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c21183 · Cited by 4
CRISPR-Cas9-Loaded Lipid Nanoparticles: A Promising Strategy for Targeted Gene Editing and Therapy
Ebrahimi-Khezrabad, S., Aghdasia, M., Zare‐Zardini, H., Eslami, H., & Eskandari, F. (2025) · BioNanoScience · doi:10.1007/s12668-025-02094-z · Cited by 5
Elwakil, M. M. A., Ni, J., Ramsay-Burrough, S., Hurst, P. J., McClellan, R. L., Khasnavis, S. R., Jia, Y., Masud, S. R., Blake, T. R., Sallets, A., et al. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.5c06654 · Cited by 5
Ullmann, K., Fachet, L., Nirschl, H., & Leneweit, G. (2023) · Gels · doi:10.3390/gels9100803 · Cited by 4
“These deficits kindled the recent elaboration of novel synthetic PLs that enable organ-selective mRNA delivery and CRISPR–Cas gene editing [11].”
BackgroundDelivery of Rna Drugs: Beyond the Liver, More than Vaccine
Elnaggar, M. G., He, Y., & Yeo, Y. (2023) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2024.114203 · Cited by 4
Metadata
- Authors
- Liu, S., Cheng, Q., Wei, T., Yu, X., Johnson, L. T., Farbiak, L., & Siegwart, D. J.
- Affiliations
- Harold C. Simmons Comprehensive Cancer Center (US)
- Corresponding author
- Siegwart, Daniel J.
- Venue
- Nature Materials
- Published
- 2021-02-04
- Volume
- 20
- Issue
- 5
- Pages
- 701-710
- ISSN
- 1476-1122 (ISSN-L)
- 1476-4660
- PMC
- PMC8188687
- OpenAlex
- W3127944141
- Cited by
- 653
- References
- 54
- Citations by year
- 2026: 107 · 2025: 154 · 2024: 139 · 2023: 122 · 2022: 90 · 2021: 40
- FWCI
- 30.66
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature Materials (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Cancer Prevention and Research Institute of Texas (RP160157)
- U.S. Department of Health & Human Services | National Institutes of Health (R01 EB025192-01A1)
- American Cancer Society (RSG-17-012-01)
- Welch Foundation (I-1855)
- Cystic Fibrosis Foundation (SIEGWA18XX0)
- U.S. Department of Health & Human Services | NIH | National Cancer Institute (5P30CA142543)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Physical Sciences › Materials Science › Polymers and Plastics › Dendrimers and Hyperbranched Polymers
- Keywords
- endosomal escape, mRNA delivery, CRISPR/Cas9 genome editing, lipid nanoparticles, zwitterionic lipids, membrane perturbation, structure-activity relationship, helper lipids, nucleic acid therapeutics
- MeSH terms
- Gene Editing, Animals, Cell Line, Cell Membrane, Female, Organ Specificity, Phospholipids, RNA, Messenger, Drug Delivery Systems, Mice, Administration, Intravenous, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
